RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp Builds European Market Presence, page-203

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 2,574 Posts.
    lightbulb Created with Sketch. 4962
    6A906695_RAP (1).pdf

    “Comparing these results to our Australian Breathe Easy study, we see the result of differing
    clinical practices between Australia and the United States, driven by a substantially different healthcare and insurance system. We also see a large number of patients (33%) requiring a third adjudicator, illustrating the difficulty in making a clinical diagnosis even with access to all the tests available in a modern tertiary hospital.”

    In a separate announcement a few weeks later as a follow-on to the SmartCough-C2 study
    The diagnosis of croup even had a 54% disagreement between adjudicators were a third adjudicator was required can you believe it! You would think with croup the diagnosis would be far easier to distinguish between as I believe kids with croup have a seal bark type of cough and Strider. Not sure how this could be missed 54% of the time?!


    Cheers

    Red bar
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.